A Single Centre, Controlled, Investigation to Evaluate the Performance of the Hyperspectral Camera for Retinal Non-invasive Examination Through the Observation of Retinal Oxygenation

Status: Unknown
Location: See location...
Intervention Type: Drug, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

An explorative study of the Mantis Photonics hyperspectral camera for retinal imaging and estimation of retinal oxygenation. Primary objective: To evaluate the performance of the hyperspectral camera for non-invasive retinal examination in order to improve the diagnosis of diseases affecting the retina or central nervous system. Secondary objective: To investigate the possibilities of the use of a hyperspectral camera for non-invasive retinal examination.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• 1\. Presence of eye disease, eye trauma, diabetes or pregnancy. 3. Inclusion in other ongoing investigations at present that would preclude the subject from participating in this investigation as judged by the Principal Investigator.

Locations
Other Locations
Sweden
Sundets Ögonläkare
Helsingborg
Time Frame
Start Date: 2022-10
Completion Date: 2023-12
Participants
Target number of participants: 120
Treatments
Experimental: Camera test group
The Principal Investigator will take a hyperspectral image of all subjects, both healthy volunteers and patients.
Sponsors
Leads: Mantis Photonics AB
Collaborators: Sundets Ögonläkare

This content was sourced from clinicaltrials.gov